4//SEC Filing
Horn Kinney 4
Accession 0001415889-22-000480
CIK 0001750284other
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 8:21 PM ET
Size
8.9 KB
Accession
0001415889-22-000480
Insider Transaction Report
Form 4
Horn Kinney
Chief Business Officer
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2022-01-10−5,251→ 152,289 totalExercise: $2.06Exp: 2030-06-09→ Common Stock (5,251 underlying) - Exercise/Conversion
Common Stock
2022-01-10$2.06/sh+5,251$10,838→ 7,709 total - Sale
Common Stock
2022-01-10$6.85/sh−5,251$35,969→ 2,458 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
- [F2]The weighted average sale price for the transaction reported was $6.85, and the range of prices were between $6.60 and $7.22. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.
Documents
Issuer
Olema Pharmaceuticals, Inc.
CIK 0001750284
Entity typeother
Related Parties
1- filerCIK 0001831215
Filing Metadata
- Form type
- 4
- Filed
- Jan 10, 7:00 PM ET
- Accepted
- Jan 11, 8:21 PM ET
- Size
- 8.9 KB